Lineage Cell Therapeutics Inc. — Director's Dealing 2018

Jul 4, 2018

_________ false

������� ����	2 352
.BIOTIME, INC
Corporation no: 876343	10834
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C004 ( Public )		Reported via MAGNA:	04/07/2018
	www.isa.gov.il			www.tase.co.il				Reference:	2018-02-059643	Time of broadcast: 09:42 09:34:10

---

Immediate report on other matterDon't use this form if there is more adequate one

	Delay the publication of a report	_________	_________

1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES - FORM 4 - MULROY MICHAEL H. ������ ������ ���� ����� MULROY MICHAEL H.

Attached file MULROY_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 01/07/2018
Address: HARBOR BAY PARKWAY 1301 , ALAMEDA 94502   CALIFORNIA , U.S.A Tel: 5105213390 , Fax: 5105213389
E-mail address: info@biotimeinc.com   Company site: biotimeinc.com
Previous names of reporting entity:
Name of the Signatory: Gerzi Ilan Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company: PEARL COHEN ZEDEK LATZER BARATZ
Address: Derech Menachem Begin 132 , Tel-Aviv 6702101 Telephone: 03-6073777 Facsimile: 03-6073778 E-mail: Igerzi@pearlcohen.com 1
U.S.A